Fetal Bovine Serum: Risk Management

by William Siegel
Volume 15, Issue 1 (Spring 2016)

Safety is typically viewed, perhaps unconsciously, as the result of a collection of factors, conditions, or behaviors. For example, consider “safety” in the context of personal, financial, or travel. With each, safety is defined as a set of component risks that have been managed to satisfactory levels for a particular situation. The same is true for product safety and risk, whether it be for raw materials or finished goods. The “safe” use of fetal bovine serum (FBS) is achieved by the management of controllable risks to a level that is acceptable for each particular application. For example, risk reduction requirements for research applications are not as stringent as for diagnostic, therapeutic, or manufacturing applications. Each end-user must decide on the level of risk reduction that is appropriate for their application...

Citation:
Siegel W. Fetal bovine serum: risk management. BioProcess J, 2016; 15(1): 22–5. https://dx.doi.org/10.12665/J151.Siegel.

Posted online April 7, 2016.